tiprankstipranks
Trending News
More News >
Sotera Health Company (SHC)
NASDAQ:SHC
US Market

Sotera Health (SHC) Earnings Dates, Call Summary & Reports

Compare
189 Followers

Earnings Data

Report Date
Apr 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.18
Last Year’s EPS
0.14
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicated solid operational and financial progress: full-year revenue and adjusted EBITDA growth, margin expansion (~118 bps), strong free cash flow ($210M), reduced leverage (3.2x), lowered interest costs and concrete commercial and regulatory achievements (customer satisfaction >80%, Nordion license renewal, XBU growth). Offsetting items were notable: Nordion experienced a sizable quarter-over-quarter revenue and income decline due to harvest timing, Nelson Labs faced advisory headwinds and Q1 softness, Sterigenics has a weaker commercial cohort and a soft start to 2026, and near-term margin/CapEx pressure from greenfield X-ray build and rising depreciation. Overall, the positives (consistent growth, margin expansion, cash generation, balance sheet improvements and clear guidance) outweigh the transitory and segment-specific headwinds.
Company Guidance
Sotera guided 2026 full‑year revenue of $1.233–$1.251 billion (5.0%–6.5% constant‑currency growth, with an estimated ~100 bps foreign‑currency tailwind weighted to H1 and largest in Q1) and adjusted EBITDA of $632–$641 million (5.5%–7.0% CC growth; implied adjusted EBITDA margin ≈51.2% at the midpoints, slightly above 2025’s 51%), with company pricing around the midpoint of its 3%–4% long‑term range. By segment, Sterigenics is expected to deliver mid‑ to high‑single‑digit CC revenue growth (Q1 mid‑single digits; Q1 the lightest quarter), Nordion low‑ to mid‑single‑digit CC growth (H1 ≈40%–45% of FY revenue, Q2 heavier than Q1), and Nelson Labs low‑single‑digit CC growth for the year with Q1 down low‑ to mid‑single digits. Other guidance assumptions include interest expense of $135–$145 million, an adjusted net‑income tax rate of 27%–29%, adjusted EPS of $0.93–$1.01, higher depreciation, diluted weighted‑average shares of ~289–291 million, capital expenditures of $175–$225 million, continued reduction in net leverage, and no assumed M&A.
Full-Year Revenue Growth
2025 total company revenue increased 5.7% to $1.164 billion (5.2% constant currency vs. 2024). 2026 revenue guidance of $1.233B–$1.251B (5%–6.5% constant currency growth).
Adjusted EBITDA Expansion and Margin Improvement
Adjusted EBITDA grew 8.2% to $593.8 million (7.8% constant currency). Adjusted EBITDA margin expanded to 51.0%, up ~118 basis points year-over-year. 2026 EBITDA guidance $632M–$641M (5.5%–7% cc growth).
Strong Cash Generation and Leverage Reduction
Adjusted free cash flow of $210 million in 2025. Net leverage improved to 3.2x from 3.7x in 2024. Available liquidity ~ $940 million ($345M cash, ~ $600M revolver capacity).
Sterigenics Revenue and Profit Growth
Sterigenics Q4 revenue rose 10.6% to $198M (8% constant currency). Segment income increased 10.4% to $110M (7.8% cc), driven by favorable pricing (+4.3%), volume/mix (+3.7%) and FX (+2.6%). 2026 Sterigenics expected mid- to high-single-digit cc revenue growth.
Nelson Labs Margin Expansion and Core Lab Growth
Nelson Labs expanded margins by ~312 basis points during the year. Q4 revenue increased 2.3% to $55M (nearly flat cc). Segment income rose 1.9% to $18M.
Capital Markets and Interest Cost Improvements
Repriced term loan lowering borrowing costs by 75 basis points. Paid down $86M of debt, generating ~$13M annual interest savings. Full-year interest expense improved by $9M to $156M.
Operational & Commercial Progress
Customer satisfaction exceeded 80%. XBU (cross-business-unit) customer revenue expanded 9% year-over-year. Nordion signed a cobalt development agreement with Westinghouse and PSEG and secured a 25-year Class 1B license renewal for Ottawa (longest ever issued).
Governance and Public Float Improvements
Public float increased to ~80% of outstanding shares in 2025. Strengthened governance with appointment of a lead independent director and addition of Richard Kyle to the board.

Sotera Health (SHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 2026
2026 (Q1)
0.18 / -
0.14
Feb 24, 2026
2025 (Q4)
0.24 / 0.26
0.2123.81% (+0.05)
Nov 04, 2025
2025 (Q3)
0.22 / 0.26
0.1752.94% (+0.09)
Aug 08, 2025
2025 (Q2)
0.17 / 0.20
0.195.26% (+0.01)
May 01, 2025
2025 (Q1)
0.12 / 0.14
0.137.69% (+0.01)
Feb 27, 2025
2024 (Q4)
0.20 / 0.21
0.26-19.23% (-0.05)
Nov 05, 2024
2024 (Q3)
0.18 / 0.17
0.21-19.05% (-0.04)
Aug 05, 2024
2024 (Q2)
0.17 / 0.19
0.21-9.52% (-0.02)
May 02, 2024
2024 (Q1)
0.12 / 0.13
0.130.00% (0.00)
Feb 27, 2024
2023 (Q4)
0.26 / 0.26
0.254.00% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2026
$17.49$16.72-4.40%
Nov 04, 2025
$16.61$16.43-1.08%
Aug 08, 2025
$11.22$13.97+24.51%
May 01, 2025
$11.50$12.10+5.22%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sotera Health Company (SHC) report earnings?
Sotera Health Company (SHC) is schdueled to report earning on Apr 30, 2026, Before Open (Confirmed).
    What is Sotera Health Company (SHC) earnings time?
    Sotera Health Company (SHC) earnings time is at Apr 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SHC EPS forecast?
          SHC EPS forecast for the fiscal quarter 2026 (Q1) is 0.18.